Research ArticleArticle
Interferon-α Abrogates the Suppressive Effect of Apoptotic Cells on Dendritic Cells in an In Vitro Model of Systemic Lupus Erythematosus Pathogenesis
Lucie Abeler-Dörner, Cosima C. Rieger, Bartlomiej Berger, Heiko Weyd, Daniela Gräf, Sandra Pfrang, Ingo H. Tarner, Andreas Schwarting, Hanns-Martin Lorenz, Ulf Müller-Ladner, Peter H. Krammer and Annegret Kuhn
The Journal of Rheumatology September 2013, jrheum.121299; DOI: https://doi.org/10.3899/jrheum.121299
Lucie Abeler-Dörner
From the Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, Heidelberg; Department of Rheumatology and Clinical Immunology, University of Giessen, Giessen; Internal Medicine I, Division of Rheumatology, University of Mainz, Mainz; Internal Medicine V, Division of Rheumatology, University of Heidelberg, Heidelberg; Department of Dermatology, University of Münster, Münster, Germany. Supported by a Heisenberg scholarship of the German Research Foundation (KU 1559/1-2) to Annegret Kuhn, a doctoral fellowship of the German National Academic Foundation to Lucie Abeler-Dörner, and a Heinrich F.C. Behr scholarship to Bartlomiej Berger. L. Abeler-Dörner, PhD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, currently at Peter Gorer Department of Immunobiology, King’s College, London, UK; C.C. Rieger, PhD; B. Berger; H. Weyd, PhD; D. Gräf; S. Pfrang, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center; I.H. Tarner, MD, Department of Rheumatology and Clinical Immunology, University of Giessen; A. Schwarting, MD, Internal Medicine I, Division of Rheumatology, University of Mainz; H-M. Lorenz, MD, Internal Medicine V, Division of Rheumatology, University of Heidelberg; U. Müller-Ladner, MD, Department of Rheumatology and Clinical Immunology, University of Giessen; P.H. Krammer, MD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center; A. Kuhn, MD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, and Department of Dermatology, University of Munster. L. Abeler-Dörner, C. Rieger, B. Berger, and H. Weyd contributed equally to this work. Address correspondence to Dr. A. Kuhn, Department of Dermatology, University of Münster, Von-Esmarch-Strasse 58, D-48149 Münster, Germany. E-mail: kuhnan@uni-muenster.de Accepted for publication July 19, 2013.
Cosima C. Rieger
From the Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, Heidelberg; Department of Rheumatology and Clinical Immunology, University of Giessen, Giessen; Internal Medicine I, Division of Rheumatology, University of Mainz, Mainz; Internal Medicine V, Division of Rheumatology, University of Heidelberg, Heidelberg; Department of Dermatology, University of Münster, Münster, Germany. Supported by a Heisenberg scholarship of the German Research Foundation (KU 1559/1-2) to Annegret Kuhn, a doctoral fellowship of the German National Academic Foundation to Lucie Abeler-Dörner, and a Heinrich F.C. Behr scholarship to Bartlomiej Berger. L. Abeler-Dörner, PhD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, currently at Peter Gorer Department of Immunobiology, King’s College, London, UK; C.C. Rieger, PhD; B. Berger; H. Weyd, PhD; D. Gräf; S. Pfrang, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center; I.H. Tarner, MD, Department of Rheumatology and Clinical Immunology, University of Giessen; A. Schwarting, MD, Internal Medicine I, Division of Rheumatology, University of Mainz; H-M. Lorenz, MD, Internal Medicine V, Division of Rheumatology, University of Heidelberg; U. Müller-Ladner, MD, Department of Rheumatology and Clinical Immunology, University of Giessen; P.H. Krammer, MD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center; A. Kuhn, MD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, and Department of Dermatology, University of Munster. L. Abeler-Dörner, C. Rieger, B. Berger, and H. Weyd contributed equally to this work. Address correspondence to Dr. A. Kuhn, Department of Dermatology, University of Münster, Von-Esmarch-Strasse 58, D-48149 Münster, Germany. E-mail: kuhnan@uni-muenster.de Accepted for publication July 19, 2013.
Bartlomiej Berger
From the Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, Heidelberg; Department of Rheumatology and Clinical Immunology, University of Giessen, Giessen; Internal Medicine I, Division of Rheumatology, University of Mainz, Mainz; Internal Medicine V, Division of Rheumatology, University of Heidelberg, Heidelberg; Department of Dermatology, University of Münster, Münster, Germany. Supported by a Heisenberg scholarship of the German Research Foundation (KU 1559/1-2) to Annegret Kuhn, a doctoral fellowship of the German National Academic Foundation to Lucie Abeler-Dörner, and a Heinrich F.C. Behr scholarship to Bartlomiej Berger. L. Abeler-Dörner, PhD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, currently at Peter Gorer Department of Immunobiology, King’s College, London, UK; C.C. Rieger, PhD; B. Berger; H. Weyd, PhD; D. Gräf; S. Pfrang, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center; I.H. Tarner, MD, Department of Rheumatology and Clinical Immunology, University of Giessen; A. Schwarting, MD, Internal Medicine I, Division of Rheumatology, University of Mainz; H-M. Lorenz, MD, Internal Medicine V, Division of Rheumatology, University of Heidelberg; U. Müller-Ladner, MD, Department of Rheumatology and Clinical Immunology, University of Giessen; P.H. Krammer, MD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center; A. Kuhn, MD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, and Department of Dermatology, University of Munster. L. Abeler-Dörner, C. Rieger, B. Berger, and H. Weyd contributed equally to this work. Address correspondence to Dr. A. Kuhn, Department of Dermatology, University of Münster, Von-Esmarch-Strasse 58, D-48149 Münster, Germany. E-mail: kuhnan@uni-muenster.de Accepted for publication July 19, 2013.
Heiko Weyd
From the Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, Heidelberg; Department of Rheumatology and Clinical Immunology, University of Giessen, Giessen; Internal Medicine I, Division of Rheumatology, University of Mainz, Mainz; Internal Medicine V, Division of Rheumatology, University of Heidelberg, Heidelberg; Department of Dermatology, University of Münster, Münster, Germany. Supported by a Heisenberg scholarship of the German Research Foundation (KU 1559/1-2) to Annegret Kuhn, a doctoral fellowship of the German National Academic Foundation to Lucie Abeler-Dörner, and a Heinrich F.C. Behr scholarship to Bartlomiej Berger. L. Abeler-Dörner, PhD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, currently at Peter Gorer Department of Immunobiology, King’s College, London, UK; C.C. Rieger, PhD; B. Berger; H. Weyd, PhD; D. Gräf; S. Pfrang, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center; I.H. Tarner, MD, Department of Rheumatology and Clinical Immunology, University of Giessen; A. Schwarting, MD, Internal Medicine I, Division of Rheumatology, University of Mainz; H-M. Lorenz, MD, Internal Medicine V, Division of Rheumatology, University of Heidelberg; U. Müller-Ladner, MD, Department of Rheumatology and Clinical Immunology, University of Giessen; P.H. Krammer, MD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center; A. Kuhn, MD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, and Department of Dermatology, University of Munster. L. Abeler-Dörner, C. Rieger, B. Berger, and H. Weyd contributed equally to this work. Address correspondence to Dr. A. Kuhn, Department of Dermatology, University of Münster, Von-Esmarch-Strasse 58, D-48149 Münster, Germany. E-mail: kuhnan@uni-muenster.de Accepted for publication July 19, 2013.
Daniela Gräf
From the Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, Heidelberg; Department of Rheumatology and Clinical Immunology, University of Giessen, Giessen; Internal Medicine I, Division of Rheumatology, University of Mainz, Mainz; Internal Medicine V, Division of Rheumatology, University of Heidelberg, Heidelberg; Department of Dermatology, University of Münster, Münster, Germany. Supported by a Heisenberg scholarship of the German Research Foundation (KU 1559/1-2) to Annegret Kuhn, a doctoral fellowship of the German National Academic Foundation to Lucie Abeler-Dörner, and a Heinrich F.C. Behr scholarship to Bartlomiej Berger. L. Abeler-Dörner, PhD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, currently at Peter Gorer Department of Immunobiology, King’s College, London, UK; C.C. Rieger, PhD; B. Berger; H. Weyd, PhD; D. Gräf; S. Pfrang, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center; I.H. Tarner, MD, Department of Rheumatology and Clinical Immunology, University of Giessen; A. Schwarting, MD, Internal Medicine I, Division of Rheumatology, University of Mainz; H-M. Lorenz, MD, Internal Medicine V, Division of Rheumatology, University of Heidelberg; U. Müller-Ladner, MD, Department of Rheumatology and Clinical Immunology, University of Giessen; P.H. Krammer, MD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center; A. Kuhn, MD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, and Department of Dermatology, University of Munster. L. Abeler-Dörner, C. Rieger, B. Berger, and H. Weyd contributed equally to this work. Address correspondence to Dr. A. Kuhn, Department of Dermatology, University of Münster, Von-Esmarch-Strasse 58, D-48149 Münster, Germany. E-mail: kuhnan@uni-muenster.de Accepted for publication July 19, 2013.
Sandra Pfrang
From the Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, Heidelberg; Department of Rheumatology and Clinical Immunology, University of Giessen, Giessen; Internal Medicine I, Division of Rheumatology, University of Mainz, Mainz; Internal Medicine V, Division of Rheumatology, University of Heidelberg, Heidelberg; Department of Dermatology, University of Münster, Münster, Germany. Supported by a Heisenberg scholarship of the German Research Foundation (KU 1559/1-2) to Annegret Kuhn, a doctoral fellowship of the German National Academic Foundation to Lucie Abeler-Dörner, and a Heinrich F.C. Behr scholarship to Bartlomiej Berger. L. Abeler-Dörner, PhD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, currently at Peter Gorer Department of Immunobiology, King’s College, London, UK; C.C. Rieger, PhD; B. Berger; H. Weyd, PhD; D. Gräf; S. Pfrang, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center; I.H. Tarner, MD, Department of Rheumatology and Clinical Immunology, University of Giessen; A. Schwarting, MD, Internal Medicine I, Division of Rheumatology, University of Mainz; H-M. Lorenz, MD, Internal Medicine V, Division of Rheumatology, University of Heidelberg; U. Müller-Ladner, MD, Department of Rheumatology and Clinical Immunology, University of Giessen; P.H. Krammer, MD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center; A. Kuhn, MD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, and Department of Dermatology, University of Munster. L. Abeler-Dörner, C. Rieger, B. Berger, and H. Weyd contributed equally to this work. Address correspondence to Dr. A. Kuhn, Department of Dermatology, University of Münster, Von-Esmarch-Strasse 58, D-48149 Münster, Germany. E-mail: kuhnan@uni-muenster.de Accepted for publication July 19, 2013.
Ingo H. Tarner
From the Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, Heidelberg; Department of Rheumatology and Clinical Immunology, University of Giessen, Giessen; Internal Medicine I, Division of Rheumatology, University of Mainz, Mainz; Internal Medicine V, Division of Rheumatology, University of Heidelberg, Heidelberg; Department of Dermatology, University of Münster, Münster, Germany. Supported by a Heisenberg scholarship of the German Research Foundation (KU 1559/1-2) to Annegret Kuhn, a doctoral fellowship of the German National Academic Foundation to Lucie Abeler-Dörner, and a Heinrich F.C. Behr scholarship to Bartlomiej Berger. L. Abeler-Dörner, PhD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, currently at Peter Gorer Department of Immunobiology, King’s College, London, UK; C.C. Rieger, PhD; B. Berger; H. Weyd, PhD; D. Gräf; S. Pfrang, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center; I.H. Tarner, MD, Department of Rheumatology and Clinical Immunology, University of Giessen; A. Schwarting, MD, Internal Medicine I, Division of Rheumatology, University of Mainz; H-M. Lorenz, MD, Internal Medicine V, Division of Rheumatology, University of Heidelberg; U. Müller-Ladner, MD, Department of Rheumatology and Clinical Immunology, University of Giessen; P.H. Krammer, MD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center; A. Kuhn, MD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, and Department of Dermatology, University of Munster. L. Abeler-Dörner, C. Rieger, B. Berger, and H. Weyd contributed equally to this work. Address correspondence to Dr. A. Kuhn, Department of Dermatology, University of Münster, Von-Esmarch-Strasse 58, D-48149 Münster, Germany. E-mail: kuhnan@uni-muenster.de Accepted for publication July 19, 2013.
Andreas Schwarting
From the Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, Heidelberg; Department of Rheumatology and Clinical Immunology, University of Giessen, Giessen; Internal Medicine I, Division of Rheumatology, University of Mainz, Mainz; Internal Medicine V, Division of Rheumatology, University of Heidelberg, Heidelberg; Department of Dermatology, University of Münster, Münster, Germany. Supported by a Heisenberg scholarship of the German Research Foundation (KU 1559/1-2) to Annegret Kuhn, a doctoral fellowship of the German National Academic Foundation to Lucie Abeler-Dörner, and a Heinrich F.C. Behr scholarship to Bartlomiej Berger. L. Abeler-Dörner, PhD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, currently at Peter Gorer Department of Immunobiology, King’s College, London, UK; C.C. Rieger, PhD; B. Berger; H. Weyd, PhD; D. Gräf; S. Pfrang, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center; I.H. Tarner, MD, Department of Rheumatology and Clinical Immunology, University of Giessen; A. Schwarting, MD, Internal Medicine I, Division of Rheumatology, University of Mainz; H-M. Lorenz, MD, Internal Medicine V, Division of Rheumatology, University of Heidelberg; U. Müller-Ladner, MD, Department of Rheumatology and Clinical Immunology, University of Giessen; P.H. Krammer, MD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center; A. Kuhn, MD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, and Department of Dermatology, University of Munster. L. Abeler-Dörner, C. Rieger, B. Berger, and H. Weyd contributed equally to this work. Address correspondence to Dr. A. Kuhn, Department of Dermatology, University of Münster, Von-Esmarch-Strasse 58, D-48149 Münster, Germany. E-mail: kuhnan@uni-muenster.de Accepted for publication July 19, 2013.
Hanns-Martin Lorenz
From the Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, Heidelberg; Department of Rheumatology and Clinical Immunology, University of Giessen, Giessen; Internal Medicine I, Division of Rheumatology, University of Mainz, Mainz; Internal Medicine V, Division of Rheumatology, University of Heidelberg, Heidelberg; Department of Dermatology, University of Münster, Münster, Germany. Supported by a Heisenberg scholarship of the German Research Foundation (KU 1559/1-2) to Annegret Kuhn, a doctoral fellowship of the German National Academic Foundation to Lucie Abeler-Dörner, and a Heinrich F.C. Behr scholarship to Bartlomiej Berger. L. Abeler-Dörner, PhD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, currently at Peter Gorer Department of Immunobiology, King’s College, London, UK; C.C. Rieger, PhD; B. Berger; H. Weyd, PhD; D. Gräf; S. Pfrang, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center; I.H. Tarner, MD, Department of Rheumatology and Clinical Immunology, University of Giessen; A. Schwarting, MD, Internal Medicine I, Division of Rheumatology, University of Mainz; H-M. Lorenz, MD, Internal Medicine V, Division of Rheumatology, University of Heidelberg; U. Müller-Ladner, MD, Department of Rheumatology and Clinical Immunology, University of Giessen; P.H. Krammer, MD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center; A. Kuhn, MD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, and Department of Dermatology, University of Munster. L. Abeler-Dörner, C. Rieger, B. Berger, and H. Weyd contributed equally to this work. Address correspondence to Dr. A. Kuhn, Department of Dermatology, University of Münster, Von-Esmarch-Strasse 58, D-48149 Münster, Germany. E-mail: kuhnan@uni-muenster.de Accepted for publication July 19, 2013.
Ulf Müller-Ladner
From the Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, Heidelberg; Department of Rheumatology and Clinical Immunology, University of Giessen, Giessen; Internal Medicine I, Division of Rheumatology, University of Mainz, Mainz; Internal Medicine V, Division of Rheumatology, University of Heidelberg, Heidelberg; Department of Dermatology, University of Münster, Münster, Germany. Supported by a Heisenberg scholarship of the German Research Foundation (KU 1559/1-2) to Annegret Kuhn, a doctoral fellowship of the German National Academic Foundation to Lucie Abeler-Dörner, and a Heinrich F.C. Behr scholarship to Bartlomiej Berger. L. Abeler-Dörner, PhD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, currently at Peter Gorer Department of Immunobiology, King’s College, London, UK; C.C. Rieger, PhD; B. Berger; H. Weyd, PhD; D. Gräf; S. Pfrang, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center; I.H. Tarner, MD, Department of Rheumatology and Clinical Immunology, University of Giessen; A. Schwarting, MD, Internal Medicine I, Division of Rheumatology, University of Mainz; H-M. Lorenz, MD, Internal Medicine V, Division of Rheumatology, University of Heidelberg; U. Müller-Ladner, MD, Department of Rheumatology and Clinical Immunology, University of Giessen; P.H. Krammer, MD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center; A. Kuhn, MD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, and Department of Dermatology, University of Munster. L. Abeler-Dörner, C. Rieger, B. Berger, and H. Weyd contributed equally to this work. Address correspondence to Dr. A. Kuhn, Department of Dermatology, University of Münster, Von-Esmarch-Strasse 58, D-48149 Münster, Germany. E-mail: kuhnan@uni-muenster.de Accepted for publication July 19, 2013.
Peter H. Krammer
From the Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, Heidelberg; Department of Rheumatology and Clinical Immunology, University of Giessen, Giessen; Internal Medicine I, Division of Rheumatology, University of Mainz, Mainz; Internal Medicine V, Division of Rheumatology, University of Heidelberg, Heidelberg; Department of Dermatology, University of Münster, Münster, Germany. Supported by a Heisenberg scholarship of the German Research Foundation (KU 1559/1-2) to Annegret Kuhn, a doctoral fellowship of the German National Academic Foundation to Lucie Abeler-Dörner, and a Heinrich F.C. Behr scholarship to Bartlomiej Berger. L. Abeler-Dörner, PhD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, currently at Peter Gorer Department of Immunobiology, King’s College, London, UK; C.C. Rieger, PhD; B. Berger; H. Weyd, PhD; D. Gräf; S. Pfrang, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center; I.H. Tarner, MD, Department of Rheumatology and Clinical Immunology, University of Giessen; A. Schwarting, MD, Internal Medicine I, Division of Rheumatology, University of Mainz; H-M. Lorenz, MD, Internal Medicine V, Division of Rheumatology, University of Heidelberg; U. Müller-Ladner, MD, Department of Rheumatology and Clinical Immunology, University of Giessen; P.H. Krammer, MD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center; A. Kuhn, MD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, and Department of Dermatology, University of Munster. L. Abeler-Dörner, C. Rieger, B. Berger, and H. Weyd contributed equally to this work. Address correspondence to Dr. A. Kuhn, Department of Dermatology, University of Münster, Von-Esmarch-Strasse 58, D-48149 Münster, Germany. E-mail: kuhnan@uni-muenster.de Accepted for publication July 19, 2013.
Annegret Kuhn
From the Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, Heidelberg; Department of Rheumatology and Clinical Immunology, University of Giessen, Giessen; Internal Medicine I, Division of Rheumatology, University of Mainz, Mainz; Internal Medicine V, Division of Rheumatology, University of Heidelberg, Heidelberg; Department of Dermatology, University of Münster, Münster, Germany. Supported by a Heisenberg scholarship of the German Research Foundation (KU 1559/1-2) to Annegret Kuhn, a doctoral fellowship of the German National Academic Foundation to Lucie Abeler-Dörner, and a Heinrich F.C. Behr scholarship to Bartlomiej Berger. L. Abeler-Dörner, PhD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, currently at Peter Gorer Department of Immunobiology, King’s College, London, UK; C.C. Rieger, PhD; B. Berger; H. Weyd, PhD; D. Gräf; S. Pfrang, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center; I.H. Tarner, MD, Department of Rheumatology and Clinical Immunology, University of Giessen; A. Schwarting, MD, Internal Medicine I, Division of Rheumatology, University of Mainz; H-M. Lorenz, MD, Internal Medicine V, Division of Rheumatology, University of Heidelberg; U. Müller-Ladner, MD, Department of Rheumatology and Clinical Immunology, University of Giessen; P.H. Krammer, MD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center; A. Kuhn, MD, Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, and Department of Dermatology, University of Munster. L. Abeler-Dörner, C. Rieger, B. Berger, and H. Weyd contributed equally to this work. Address correspondence to Dr. A. Kuhn, Department of Dermatology, University of Münster, Von-Esmarch-Strasse 58, D-48149 Münster, Germany. E-mail: kuhnan@uni-muenster.de Accepted for publication July 19, 2013.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Interferon-α Abrogates the Suppressive Effect of Apoptotic Cells on Dendritic Cells in an In Vitro Model of Systemic Lupus Erythematosus Pathogenesis
Lucie Abeler-Dörner, Cosima C. Rieger, Bartlomiej Berger, Heiko Weyd, Daniela Gräf, Sandra Pfrang, Ingo H. Tarner, Andreas Schwarting, Hanns-Martin Lorenz, Ulf Müller-Ladner, Peter H. Krammer, Annegret Kuhn
The Journal of Rheumatology Sep 2013, jrheum.121299; DOI: 10.3899/jrheum.121299
Interferon-α Abrogates the Suppressive Effect of Apoptotic Cells on Dendritic Cells in an In Vitro Model of Systemic Lupus Erythematosus Pathogenesis
Lucie Abeler-Dörner, Cosima C. Rieger, Bartlomiej Berger, Heiko Weyd, Daniela Gräf, Sandra Pfrang, Ingo H. Tarner, Andreas Schwarting, Hanns-Martin Lorenz, Ulf Müller-Ladner, Peter H. Krammer, Annegret Kuhn
The Journal of Rheumatology Sep 2013, jrheum.121299; DOI: 10.3899/jrheum.121299